MAGELLAN LONGEVITY
HomeTopical Pain Relief › Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol)

Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol)

Written and medically reviewed by , physiatrist · Last reviewed · How we grade
In one paragraph

Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol) — a 2024 trial of a related salicylate/camphor topical found it non-inferior to topical diclofenac. After application, methyl salicylate is hydrolyzed in the skin to salicylic acid, providing weak local COX/prostaglandin inhibition together with rubefacient vasodilation (increased skin blood flow), while menthol activates cold-sensing TRPM8 receptors on sensory nerves to produce a cooling sensation that masks pain and desensitizes nociceptors.

Source: CJEM 2025, PMID 40952589 ↗ · Topical Pain Relief · How Magellan grades evidence · Study write-up · evidence confidence: high

Topical Pain Relief18 PubMed citations
$16.97 typical listed price — check the live price on Amazon
View Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol) on Amazon ↗   Open in the Magellan store →

What it is

Salonpas Pain Relieving Patch delivers two topical counterirritant analgesics through the skin over a painful area: methyl salicylate (a salicylate ester chemically related to aspirin) and menthol, in an occlusive patch formulation approved by the FDA in 2010. After application, methyl salicylate is hydrolyzed in the skin to salicylic acid, providing weak local COX/prostaglandin inhibition together with rubefacient vasodilation (increased skin blood flow), while menthol activates cold-sensing TRPM8 receptors on sensory nerves to produce a cooling sensation that masks pain and desensitizes nociceptors. The combination is sold over the counter for temporary relief of minor muscle and joint aches, strains, sprains, and arthritis pain.

Its role in longevity

Randomized trials of methyl-salicylate/menthol patches and menthol-based topical products show modest, short-term reductions in pain from muscle strain and other musculoskeletal complaints — in the pivotal multicenter trial of this formulation class (208 patients), a single 8-hour patch beat placebo on day-1 pain relief with adverse-event rates similar to placebo — and a large Cochrane overview finds good evidence that some topical analgesics help acute sprains and strains. A 2024 trial of a related salicylate/camphor topical found it non-inferior to topical diclofenac. The evidence is still genuinely mixed: systematic reviews of topical salicylate rubefacients report only moderate-to-poor efficacy for chronic musculoskeletal pain, and long-term data are lacking. These agents are generally well tolerated, but percutaneous salicylate absorption has potentiated warfarin anticoagulation in a case report, and occlusive or misused counterirritant topicals have caused chemical burns. This evidence describes topical menthol and methyl salicylate and their mechanisms in general, not this specific commercial patch.

The research

Peer-reviewed studies on the active compound — citations link to PubMed.

“Findings suggest topical NSAIDs may be effective and well tolerated for managing acute musculoskeletal pain; interventions included ketoprofen gel, methyl salicylate/1-menthol patch, and diclofenac epolamine patch.”
CJEM 2025 · PMID 40952589
“Both ibuprofen/levomenthol and diclofenac gels provided superior global pain relief compared with ibuprofen gel, with a shorter median time to significant pain relief. Only ibuprofen/levomenthol gel provided cooling for up to 2 hours.”
J Int Med Res 2019 · PMID 31353997
“The primary efficacy analysis (SPID8 with movement) indicated that patients receiving the active patch experienced significantly greater pain relief (approximately 40%) than those patients receiving a placebo patch (mean [SD], 182.6 [131.2] vs 130.1 [144.1]; P = 0.005).”
Clin Ther 2010 · PMID 20171409
“At day 14, TG pain severity score and pain interference score decreased (49% and 58.1%, respectively).”
J Pain Res 2020 · PMID 32617016
“A menthol-based topical analgesic increased PPT (decreased pain sensitivity) overall (P = .05; 11.6% [2.4%]; d = 1.05) and PPT was higher (P < .0001; 31.5%-44.2%; d = 1.03-1.8) for lower versus upper body locations.”
J Sport Rehabil 2021 · PMID 34552033
“No significant improvement was observed with topical 1% diclofenac/3% menthol gel compared with placebo, 1% diclofenac, or 3% menthol gel in treating pain from ankle sprain.”
J Int Med Res 2017 · PMID 28345425

Research describes the active mechanism and is not a claim about this specific product.

Educational information, not medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if pregnant, nursing, or taking medication.

More in Topical Pain Relief

Voltaren Arthritis Pain Gel (Diclofenac 1%)

Randomized trials and meta-analyses, including Cochrane reviews, indicate that topical…

Capzasin-HP Capsaicin 0.1% Pain Relief Cream

Randomized trials and meta-analyses show that topical capsaicin produces modest…

Aspercreme 4% Lidocaine Pain Relief Cream

The best-supported use of topical lidocaine is localized neuropathic pain, especially…

Biofreeze Menthol Pain Relief Gel

Menthol is used for the temporary relief of minor muscle and joint pain, including…

See all Topical Pain Relief →

FAQ

Does Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol) have scientific evidence?

Yes — its active compound is linked to 18 peer-reviewed studies, summarized and cited above.

Where can I buy Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol)?

You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.

Is Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol) safe?

Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.